Abstract Classic derivation of mouse embryonic stem (ES) cells from blastocysts is inefficient, strain-dependent, and requires expert skills. Over recent years, several major improvements have greatly increased the success rate for deriving mouse ES cell lines. The first improvement was the establishment of a user-friendly and reproducible medium-alternating protocol that allows isolation of ES cells from C57BL/6 transgenic mice with efficiencies of up to 75%. A recent report describes the use of this protocol in combination with leukemia inhibitory factor and pluripotin treatment, which made it possible to obtain ES cells from F1 strains with high efficiency. We report modifications of these protocols for user-friendly and reproducible derivation of mouse ES cells with efficiencies of up to 100%. Our protocol involves a long initial incubation of primary outgrowths from blastocysts with pluripotin, which results in the formation of large spherical outgrowths. These outgrowths are morphologically distinct from classical inner cell mass (ICM) outgrowths and can be easily picked and trypsinized. Pluripotin was omitted after the first trypsinization because we found that it blocks attachment of ES cells to the feeder layer and its removal facilitated formation of ES cell colonies. The newly established ES cells exhibited normal karyotypes and generated chimeras. In summary, our user-friendly modified protocol allows formation of large spherical ICM outgrowths in a robust and reliable manner. These outgrowths gave rise to ES cell lines with success rates of up to 100%.
Introduction
Embryonic stem (ES) cells are capable of self renewal and differentiation into all types of embryonic and adult cells, including the germ-cell lineage. Mouse ES cells are usually isolated from the inner cell mass (ICM) of blastocysts. The first mouse ES cell lines were derived almost 30 years ago [1, 2] , but the classical way for isolating mouse ES cells is very inefficient. It is highly dependent on the strain, and it requires expert skills [3] . Several major improvements have greatly increased the success rate for deriving mouse ES cell lines. These improvements include the use of a defined serum-free medium (knockout serum replacement, SR) [4] , alternating between ES cell media containing SR and fetal bovine serum (FBS) [3] , and the use of pharmacological compounds [5] [6] [7] [8] . In addition, mouse and rat ES cells could be isolated and maintained in a chemically defined medium containing three (3i) or two (2i) small-molecule inhibitors and without the need for extrinsic stimuli, such as serum factors, MEFs, LIF or BMP4 [9] [10] [11] . Pluripotin, a small synthetic molecule, allows the propagation of mouse ES cells in an undifferentiated state in the absence of leukemia inhibitory factor (LIF) and mouse embryonic fibroblasts (MEFs) [12] . Finally, combining an SR/FBS medium alternation protocol with the use of MEFs, LIF and pluripotin made it possible to derive mouse ES cells from F1 strains (C57BL/6 transgenics × CD1) with high efficiency [13] .
Bryja and colleagues developed a simple and userfriendly protocol that allows investigators with basic cell culture skills and standard equipment to derive ES cells [3] . However, the efficiency of their ES cell isolation protocol is only about 50% [3] . Blastocysts were plated and grown for 6 days in SR-ES cell medium. Blastocyst outgrowths were trypsinized and plated in FBS-ES cell medium and then shifted back to SR-ES cell medium the following day. After two more passages, alternating between ES cell media containing SR and FBS, ES cell lines were established and frozen. Yang and colleagues [13] modified this SR/FBS medium alternation protocol in two ways. First, blastocysts were plated and grown for 2 days in FBS-ES cell medium followed by different incubation periods (1-12 days) in SR-ES cell medium. Second, pluripotin was added to the ES cell media during the first three passages. This procedure allowed highly efficient derivation of ES cells [13] .
We established a user-friendly and highly reproducible pluripotin-based ES cell derivation protocol starting from previously published protocols [3, 13] . By using our modified procedure, we were able to isolate mouse ES cell lines from wild-type C57BL/6 blastocysts as well as from seven transgenic mouse strains with efficiencies of up to 100% (Table 1) . This high success rate was reproduced independently by two other researchers (Table 1) . We modified the previously published protocols [3, 13] by culturing primary outgrowths from blastocysts for 12 days in pluripotin-containing SR-ES cell medium and by omitting pluripotin after the first trypsinization (Fig. 1) . Prolonged cultivation of primary outgrowths in the presence of pluripotin resulted in the formation of large spheres composed of pluripotent cells that were morphologically distinct from classical ICM outgrowths (Fig. 2 , compare panel a to b or c). These spheres were mostly loosely attached to their substrate and often appeared in suspension; in both cases, mouse ES cell lines could be readily isolated from them. The large spherical outgrowths were easy to pick, and after a single trypsinization step, they were readily dissociated into single cells and plated on MEFs in FBS-containing ES-cell medium. When pluripotin was present in the FBS-containing ES cell medium, most of the cells failed to attach to the MEF layer and were lost when changing the medium to SR-containing ES cell medium. In contrast, when the dissociated cells were seeded in the absence of pluripotin, they attached readily to the MEFs, and primary ES cell colonies were formed efficiently within days. The loosely attached spherical outgrowths facilitate the isolation of ES cells in several ways. First, our protocol yields large outgrowths (300-500 μm), containing several thousand cells. This provides a lot of starting material before the first trypsinization. In contrast, the outgrowths obtained according to published reports are much smaller (100 μm) [3, 13] . Second, the spherical outgrowths (obtained by our protocol) are loosely attached to the MEFs and are easy to pick and trypsinize. In contrast, the primary outgrowths obtained by the protocol of Yang and colleagues are strongly attached to the feeder layer and are difficult to pick [13] . In addition, these outgrowths are hard to dissociate and require an additional collagenase IV treatment [13] . Other differences between our ES cell procedure and previously published protocols are listed in Table 2 .
In conclusion, our pluripotin-based protocol is userfriendly and very efficient (with success rates of up to 100%) and could make stem cell research feasible for a broader scientific community. In addition, it can generate both transgenic and littermate control ES cell lines, which 
Methods
Collecting Blastocysts and Morulas 1. Set up time matings: Female mice (can be superovulated) at the age of 6-16 weeks are housed with male studs. Check for copulation plugs the following morning. Plugged females are considered to be carrying 0.5 dpc (days post coitum) embryos.
2.
Sacrifice pregnant females to collect blastocysts (3.5 dpc) or morulas (2.5 dpc). Make a midventral incision and dissect from both sides a piece that consists of the uterus and the oviduct. A first cut is made in the uterus just before the cervix and a second cut is made between the ovary and the oviduct. Transfer the excised pieces to a 1.5-ml tube containing 500 μl M2 medium. Dissection should be done in a laminar air flow. 3. In a laminar air flow, transfer the uteri to bacterial grade dishes and locate the oviduct under the stereo microscope using fine forceps. The flushing procedure differs depending on whether blastocysts (4a) or morulas (4b) are to be collected. 4a. Flush blastocysts (3.5 dpc) from the uterus with a 23G needle and a 1-ml syringe filled with M2 medium. Bend the 23G needle approximately 45°and insert the needle in the end of the uterus that is closest to the oviduct. Hold the needle in place with fine forceps while pressing the plunger. Swelling of the uterus indicates successful flushing and can be monitored under the microscope. 4b. Flush morulas (2.5 dpc) from the oviduct with a blunt 32G needle and a 5-ml Luer-Lok syringe filled with M2 medium. Flushing morulas from oviducts is difficult and requires technical skill. Locate the infundibulum, the funnel-shaped end of the oviduct that is nearest to the ovary. Insert the needle in the infundibulum and the first part of the oviduct and flush while holding the needle in place with fine forceps. 5. Using a mouth pipette, collect all embryos and transfer them to a drop (approximately 250 μl) of M2 medium. Wash embryos two more times by transferring them twice to a fresh drop of M2 medium. 6. Remove the zona pellucida from morulas by treating them with Tyrode solution (Note 5). Transfer dissociated cells to the 96-well mitomycin-Ctreated MEF plate (flat bottom). 9. Next day, change medium from FBS-ES to SR-ES cell medium. 10. After 1-2 days of growth in SR-ES cell medium (refresh every day), the newly established ES cell colonies can be passaged to 24-well plates (Note 13). For that, prepare gelatinized 24-well plates (1 well/ES cell line) with mitomycin-C-treated MEFs and MEF medium (1 ml/well) 1 day in advance. Change medium from MEF to FBS-ES cell medium 1 h before the next step (trypsinization). 11. Wash the ES cell colonies (from the 96-well plate) with PBS. Add 30 μl of 0.25% trypsin to each well (in the 96-well plate) and incubate for 3 min at 37°C in 5% CO 2 . 12. Add 100 μl FBS-ES cell medium to each well, dissociate ES cell colonies into single cells by pipetting 10-15 times. Transfer dissociated cells to 24-well mitomycin-C-treated MEF plates. 13. Next day, change medium from FBS-ES to SR-ES cell medium. 14. After 1-2 days of growth in SR-ES cell medium (refresh every day), the ES cell lines can be passaged to three wells in a 24-well plate (Fig. 1) KIC/+ mice, both on a C57BL/6 background, will be reported elsewhere (Pieters et al., in preparation). ROSA26 reporter (R26R) mice [14] were backcrossed to C57BL/6. The ROSA26-antiLuc reporter mice were generated by homologous recombination in G4 ES cells [15] using the ROSA26-antiLuc construct obtained from the laboratory of Dr. Dagmar Wirth [16] . B6/129 ROSA26-antiLuc F1-hybrid mice were subsequently outbred and maintained on a mixed B6/129/Swiss background. The p120ctn null allele was generated by Cre-mediated removal of a floxed region in the p120ctn gene (containing exons 3-8) [17, 18] . 2. A mouth pipette consists of a micropipette, a micropipette holder, tubing and an aspirator mouth piece. For detail, see Nagy et al., [19] . Micropipettes can be custom made by heating the finest part of a Pasteur pipette for a few seconds in the flame of a Bunsen burner, removing the pipette from the flame, and pulling both ends. The procedure can be repeated several times until a needle with a diameter slightly larger than a blastocyst is obtained (100-200 μm). 3. All culture plates or dishes have to be coated with 0.1% gelatin. Dissolve 0.5 g in 500 ml distilled water, autoclave and store at 4°C. Before seeding the MEFs, add 0.1% gelatin to the culture plates, incubate 5 min at 37°C in 5% CO 2 and aspirate the gelatin solution. 4. Dissolve 5 mg pluripotin in 2.27 ml DMSO (4 mM, 2000X stock) and store aliquots at −20°C. Add pluripotin to the medium just before use (final concentration: 2 μM). 5. Prepare a bacterial grade plate with several drops (250 μl) of M2 medium and Tyrode solution. Transfer up to five embryos to a drop of Tyrode solution by mouth pipetting and monitor the deterioration of the zona pellucida under the microscope. When the zona starts to deteriorate, quickly transfer the embryo to a drop of M2 medium (exposure of zona-free embryos to Tyrode solution may harm them). Remains of the zona pellucida can be removed mechanically by pipetting the embryo several times up and down using a mouth pipette. Transfer embryos freed from their zona pellucida to a fresh drop of M2 medium (make sure there are no traces of Tyrode solution left in the needle of the mouth pipette).
Detailed protocols to isolate MEFs have been reported
elsewhere [20, 21] . In brief, collect E13.5 embryos, remove the head and internal organs, and trypsinize the embryonal tissue. Dissociate the tissue into single cells and plate and grow them in MEF medium on gelatinized plates. Two embryos provide sufficient cells for one 15-cm culture dish. Confluent MEF plates can be frozen immediately (passage 0) or expanded two times before freezing (passage 2). One vial of passage-2 MEFs, frozen from a confluent 15-cm dish, can be divided over three to four gelatinized culture plates (6-, 12-, 24-, or 96-well) or over three to four gelatinized 10-cm culture dishes. After 2-3 days the MEFs reach confluency and can be inactivated by treating them with Mitomycin C (10 μg/ml) for 3 h. Two milligrams of Mitomycin C is dissolved in 2 ml sterile PBS. This 100X stock can be stored at 4°C. Mitomycin C-inactivated MEFs should be washed at least three times before use. 7. Blastocysts are plated in gelatinized 12-well plates with mitomycin-C-treated MEFs (Fig. 2a, top) (Fig. 2 , compare panel a to b or c). These spheres are mostly loosely attached to the MEFs and often appear in suspension. In contrast to classic ICM outgrowths that stick to the MEFs, the loose spherical outgrowths can be lost when the medium is aspirated. Indeed, in our hands the efficiency of initial mouse ES cell isolations (using our protocol) was not maximal due to the loss of nonattached spheres while changing medium. Therefore, loose outgrowths should be transferred to an empty well filled with SR-ES cell medium using a mouth pipette and then transferred back once the medium is refreshed. The medium of outgrowths sticking to the feeder layer can either be refreshed as such or the outgrowths are picked and transferred using a mouth pipette as mentioned above; we recommend using a mouth pipette. Culturing blastocysts the first 2 days without pluripotin resulted in the formation of flat ICM outgrowths, which stay firmly attached to the underlying feeder and trophectoderm layer after pluripotin administration (Fig. 2b) . However, these flat ICM outgrowths are harder to pick and trypsinize and are less efficient (33%) in establishing ES cell lines. 10. When pluripotin was present in the FBS-containing ES cell medium, most of the cells failed to attach to the MEF layer and were lost when changing the medium to SR-containing ES cell medium. In contrast, when cells dissociated after the first trypsinization were seeded in the absence of pluripotin, they readily attached to the MEFs, and primary ES cell colonies were formed efficiently within days. 11. The primary outgrowth should have a diameter of about 300 μm at the time of trypsinization. Blastocyst outgrowths can be cultured for up to 18 days without losing their ability to form ES cell lines. The main advantage of a long initial cultivation in pluripotin-containing SR-ES cell medium is that it allows a large number of undifferentiated cells to develop before the first trypsinization. Apparently, the establishment of ES cell lines became more reliable once large pluripotent spheres were obtained: 79 initial outgrowths gave rise to 78 ES cell lines (99%). In addition, using a transgenic Oct4-EGFP line (EGFP driven by the Oct4-promoter), Yang and colleagues [13] showed that outgrowths from Oct4-EGFP blastocysts expressed EGFP for up to 14 days. Smaller outgrowths can also give rise to ES cell lines but they generate fewer colonies, which have to be cultured for longer times before they can be passaged. 12. The outgrowths are readily dissociated into single cells in a single trypsinization step. Sequential digestion, as suggested by Yang and colleagues [13] , is not required. 13. If a well of the 96-well plate contains only a few ES cell colonies, it is better to let these colonies grow for a few more days, and trypsinize (step 11) and plate them again in a new well of a 96-well mitomycin-Ctreated MEF plate (flat bottom, containing FBS-ES cell medium). Next day, change medium to SR-ES cell medium. Wait for ES cell colonies to appear and proceed again to step 11. 14. At this stage you can decide to make a freezing (Note 15) and/or a DNA preparation. For a DNA preparation, transfer one third of the ES cells (1/3 of a 24-well) to gelatinized 24-well plates (without MEFs). After 30 min, transfer the cell suspension to a new well to get rid of most of the MEFs, which would otherwise contaminate the DNA preparation. MEFs attach faster than ES cells to gelatinized plates. Genomic DNA is prepared from confluent wells according to Laird et al. [22] . Alternatively, you can speed up the ES cell isolation by transferring ES cells from two wells (of a 24-well plate) to a 6-well plate. 15. Our freezing method: ES cells (70% confluent) from a 6-well plate are trypsinized (800 μl), dissociated and centrifuged. The cell pellet is resuspended in 10% DMSO and 90% FCS (1 ml/freezing). Cells are placed on ice for 30 min and frozen at −80°C. Frozen cells are kept at −80°C for up to several weeks and in liquid nitrogen for long time storage. 16. The newly established ES cell lines could be maintained in a morphologically undifferentiated state for over 10 passages (Fig. 3a) , they expressed the transcription factor Oct-4 (Fig. 3b) , and they readily formed embryoid bodies (EBs, Fig. 3c ). Those EBs could be differentiated into various cell types (Fig. 4d) , including neurectoderm (Nestin), mesoderm (Smooth muscle actin), skeletal muscle (α-Dystrobrevin), beating cardiomyocytes (Troponin), and endothelial and hematopoietic cell types (data not shown). The procedure for forming embryoid bodies was similar to that described before [23, 24] . In brief, ES cells were feeder-depleted and Fig. 3 Properties of ES cell lines derived from pluripotintreated primary outgrowths. PFMHII (Invitrogen), 2 mM L-glutamine (Invitrogen), 0.4 mM MTG (Sigma), 50 μg/ml ascorbic acid (Sigma) and penicillin (100 U/ml)-streptomycin (100 μg/ml) (Invitrogen). EBs were allowed to form in these dishes for 10 days. The EBs were then plated unto gelatinized culture dishes and allowed to attach and spread out for 10 days in differentiation medium. The staining procedure for ES cells and plated EBs involved fixation with 4% paraformaldehyde, permeabilization with 0.2% TX-100 and incubation at room temperature for 2 h with primary antibody and 1 h with secondary antibody (Molecular Probes, Eugene, OR). The following primary antibodies were used: mouse monoclonal anti-Oct-4 (1/100, Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-Nestin (1/100, Becton Dickinson, New York), mouse mocolonal anti-Smooth muscle actin (SMA, 1/100, Sigma), mouse monoclonal anti-Troponin (1/100, Thermo Scientific, Walt ham, MA), rabbi t polycl onal anti-α -Dystrobrevin (1/200, H-300, Santa Cruz). Confocal microscopy was performed using a Leica TCS SP5 confocal scan head attached to a Leica DM IRE2 inverted microscope and a PC running Leica AF software version 2.5. 17. Chimeras were generated from different pluripotinderived ES cells (Fig. 3e) . ROSA-antiLuc ES cell lines generated weak chimeras, probably because these ES cells exhibited significant chromosomal instability as they were derived with 4 μM pluripotin (Note 18). p120ctn +/− ES cells derived with 2 μM pluripotin generated strong chimeras. Chimeras were generated by diploid aggregation. Briefly, embryos were collected on day E2.5 from superovulated Swiss female mice. Zona pellucida of embryos was removed by treatment with acid Tyrode's solution (Note 5, Sigma). ES cell colonies were briefly analyzed. An ES cell line is considered normal if 70% or more of its spreads contain 40 chromosomes. All ES cell lines derived with 4 μM pluripotin showed chromosomal instability, whereas most ES cell lines derived with 2 μM pluripotin exhibited a normal karyotype treated with 0.25% trypsin-EDTA (Invitrogen) to form loosely connected clumps of 7-10 cells. Each zona-free embryo was aggregated with a clump of 7-10 cells inside depression wells made in a 35-mm plastic dish (VWR International) with an aggregation needle (BLS Ltd, Hungary). They were cultured overnight in microdrops of KSOM with amino acids (Biognost) under mineral oil (Sigma) at 37°C in 95% air/5% CO2. The next day, blastocysts were transferred into the uteri of 2.5-dpc pseudopregnant Swiss females previously mated with vasectomized males. Chimeras were identified at birth by the presence of black eyes and later by agouti coat pigmentation.
Normal mitotic karyotype of mouse ES cells
consists of 40 acrocentric chromosomes (Fig. 4a) .
Chromosomal analysis was performed on 10 ES cell lines derived with 4 μM pluripotin. Chromosomal instability was observed in all of them (Fig. 4b) . Thus, these lines are only suitable for in vitro analysis. In contrast, ES-cell lines derived with 2 μM pluripotin during the blastocyst outgrowth phase were generated with high efficiency (100%) and these lines had a normal karyotype (Fig. 4c) . In addition, strong chimeras could be derived from these ES cell lines. Yang and colleagues [13] derived ES cells with 3-5 μM pluripotin. Their ES cells showed some chromosomal abnormalities and were not proven to be germline competent [13] . By lowering the pluripotin concentration from 4 to 2 μM, we obtained ES cells that generated strong chimeras and displayed a normal karyotype. To make mitotic spreads for counting chromosomes, ES cells were passaged to gelatinized six-well plates. Nearly confluent ES cell cultures were grown for 2 h with demecolcine (50 ng/ml, Sigma), washed with PBS, and trypsinized. Resuspended ES cells were incubated 15-20 min in warm KCl solution (75 mM) and washed four times with freshly-made cold fixative consisting of a 3:1 mixture of methanol and glacial acetic acid. ES cells were resuspended in 500 μl fixative and dispersed on three wet slides (80 μl/ slide) (SuperFrost Plus microscope slides, Klinipath). Air-dried slides were stained with DAPI and 20 individual spreads were counted. Spreads with 38 chromosomes or less were discarded. An ES cell line is considered normal if 70% or more of its spreads contain 40 chromosomes. 19. Isolation of ES cells from morulas turned out to be much less efficient (Table 3 ) due to decreased formation of primary outgrowths (32% compared to 95%). 20. Differences between our protocol and that of Yang et al. [13] are listed in Table 2 . We also compared the performance of our modified mouse ES cell derivation protocol with other protocols, including the one published by Yang and colleagues [13] . From the nine wild-type C57BL/6 blastocysts that we processed with Yang's protocol, only five formed small ICM outgrowths ( Fig. 2c ; top, DIV 10). Most outgrowths spontaneously dissociated after 10 days of culture ( Fig. 2c ; bottom, DIV 10) and no ES cell lines could be derived from them. In contrast, all six wild-type C57BL/6 blastocysts processed according to our modified protocol formed large spherical ICM outgrowths after 10 days of culture (Fig. 2a , DIV 10). ES cell lines could be established for all six outgrowths (Table 1) . Remarkably, the two pluripotin-based protocols gave rise to morphologically different ICM outgrowths. This discrepancy between our results and those of Yang and colleagues [13] might have been due to the use of different ES cell media in which blastocysts are seeded. On the first 2 days, Yang and colleagues [13] used FBS-ES cell medium (Table 2) , which might contain factors that stimulate attachment of blastocyst outgrowths to the substrate in the presence of pluripotin. These factors are probably not present in the chemically defined SR-ES cell medium that we used. On the other hand, seeding blastocysts in SR-ES cell medium alone allows attachment of the outgrowths to the MEFs and the formation of flat ICM outgrowths (Fig. 2b) . Our data indicate that pluripotin, at least in SR-ES cell medium, blocks the attachment of outgrowths to the MEFs. Such a block might promote growth and result in the formation of bigger but loosely attached outgrowths. 
